Osama Elbaz

522 total citations
17 papers, 439 citations indexed

About

Osama Elbaz is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Osama Elbaz has authored 17 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Osama Elbaz's work include Acute Myeloid Leukemia Research (5 papers), Immune Cell Function and Interaction (4 papers) and Immune Response and Inflammation (4 papers). Osama Elbaz is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Immune Cell Function and Interaction (4 papers) and Immune Response and Inflammation (4 papers). Osama Elbaz collaborates with scholars based in Egypt, Netherlands and United States. Osama Elbaz's co-authors include Bob Löwenberg, H Hoogerbrugge, LM Budel, Ruud Delwel, Shaker A. Mousa, Noureldien H. E. Darwish, Thangirala Sudha, Kavitha Godugu, I.P. Touw and R Delwel and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Molecules.

In The Last Decade

Osama Elbaz

16 papers receiving 421 citations

Peers

Osama Elbaz
Katharina M. Brauer Germany
Megan Karwan United States
Il‐Kyoo Park United States
Kouji Kato Japan
Yizhuo Zhang China
Sharon D. Luikart United States
Nancy Díaz‐Valdés Spain
Stephanie Watson United Kingdom
Maged S. Mahmoud Japan
Katherine E. Lindblad United States
Katharina M. Brauer Germany
Osama Elbaz
Citations per year, relative to Osama Elbaz Osama Elbaz (= 1×) peers Katharina M. Brauer

Countries citing papers authored by Osama Elbaz

Since Specialization
Citations

This map shows the geographic impact of Osama Elbaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osama Elbaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osama Elbaz more than expected).

Fields of papers citing papers by Osama Elbaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osama Elbaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osama Elbaz. The network helps show where Osama Elbaz may publish in the future.

Co-authorship network of co-authors of Osama Elbaz

This figure shows the co-authorship network connecting the top 25 collaborators of Osama Elbaz. A scholar is included among the top collaborators of Osama Elbaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osama Elbaz. Osama Elbaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Elbaz, Osama, et al.. (2023). Role of Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) as a prognostic marker in Egyptian patients with B-cell Chronic Lymphocytic Leukemia. The Egyptian Journal of Haematology. 48(4). 329–336. 1 indexed citations
2.
Elbaz, Osama, et al.. (2023). The Prevalence of MYD88 L265P and TNFAIP3 Mutations and Their Correlations with Clinico-Hematological Profile in Egyptian Patients with Diffuse Large B Cell Lymphoma. Asian Pacific Journal of Cancer Prevention. 24(7). 2485–2491. 1 indexed citations
3.
Darwish, Noureldien H. E., Thangirala Sudha, Kavitha Godugu, et al.. (2019). Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia. Molecules. 24(11). 2103–2103. 55 indexed citations
4.
Herman, Sarah E. M., Nakhle S. Saba, Mahfooz Farooqui, et al.. (2016). Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia. Leukemia. 31(2). 340–349. 32 indexed citations
5.
Darwish, Noureldien H. E., et al.. (2016). Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1. Oncotarget. 7(36). 57811–57820. 65 indexed citations
6.
Elbaz, Osama, et al.. (2014). Prognostic Utility of Angiogenic Growth Factors; Basic FGF, VEGF and PDGF-bb in Patients with Lymphoma. International Journal of Cancer Research. 10(2). 96–105. 2 indexed citations
7.
Elbaz, Osama, et al.. (2011). Systemic inflammatory response syndrome in patients with liver cirrhosis. Arab Journal of Gastroenterology. 12(4). 173–177. 38 indexed citations
8.
Salem, Mohammad, et al.. (2000). Identification of Predictors of Disease Status and Progression in Patients with Myeloma (MM). Hematology. 5(1). 41–45. 7 indexed citations
9.
10.
Elbaz, Osama, et al.. (1997). MUTANT P53 ONCOPROTEIN IN CHILDHOOD ACUTE LEUKEMIAS 81. Pediatric Research. 41(5). 759–759.
11.
Elbaz, Osama, et al.. (1994). Tumor Necrosis Factor and Human Acute Leukemia. Leukemia & lymphoma. 12(3-4). 191–195. 16 indexed citations
12.
Elbaz, Osama, et al.. (1992). Analysis of the TNF receptors on human leukaemia cells by affinity cross‐linking. British Journal of Haematology. 81(4). 530–532. 6 indexed citations
13.
Elbaz, Osama, Leo M. Budel, H Hoogerbrugge, et al.. (1991). Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes.. Journal of Clinical Investigation. 87(3). 838–841. 58 indexed citations
14.
15.
16.
17.
Budel, LM, Osama Elbaz, H Hoogerbrugge, et al.. (1990). Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes. Blood. 75(7). 1439–1445. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharina M. Brauer Breakdown of academic impact, for papers by Megan Karwan Breakdown of academic impact, for papers by Il‐Kyoo Park Breakdown of academic impact, for papers by Kouji Kato Breakdown of academic impact, for papers by Yizhuo Zhang Breakdown of academic impact, for papers by Sharon D. Luikart Breakdown of academic impact, for papers by Nancy Díaz‐Valdés Breakdown of academic impact, for papers by Stephanie Watson Breakdown of academic impact, for papers by Maged S. Mahmoud Breakdown of academic impact, for papers by Katherine E. Lindblad
Rankless by CCL
2026